• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质 Tau 负荷与脑白质高信号相关。

Cortical tau load is associated with white matter hyperintensities.

机构信息

Institute of Neuroscience, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK.

Department of Psychiatry, Cambridge University, Cambridge, UK.

出版信息

Acta Neuropathol Commun. 2015 Sep 30;3:60. doi: 10.1186/s40478-015-0240-0.

DOI:10.1186/s40478-015-0240-0
PMID:26419828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4589169/
Abstract

INTRODUCTION

Cerebral white matter lesions (WML), visualized as white matter hyperintensities (WMH) on T2-weighted MRI, encompass structural damage and loss of integrity of the cerebral white matter (WM) and are commonly assumed to be associated with small vessel disease (SVD). However, it has been suggested that WM damage may also be the result of degenerative axonal loss that is secondary to cortical Alzheimer's disease (AD) pathologies i.e., hyperphosphorylated tau (HPτ) and amyloid-beta (Aβ). Here we investigate the influence of HPτ, Aβ and SVD on WMH severity.

RESULTS

36 human post-mortem right fixed cerebral hemispheres (mean age 84.4 ± 7.7 years; male: 16, female: 20) containing varying amounts of AD-pathology (AD: 23, controls: 13) underwent T2- weighted MRI with WMH assessed according to the age related white matter change scale (ARWMC). After dissection, using tissue samples from the frontal, temporal, parietal and occipital regions from the right hemisphere, we quantitatively assessed cortical HPτ and Aβ pathology burden by measuring the percentage area covered by AT8 immunoreactivity (HPτ-IR) and 4G8 immunoreactivity (Aβ-IR), and assessed the severity of WM SVD by calculating the sclerotic index (SI) of WM arteries/arterioles. HPτ-IR, Aβ-IR, and SI were compared with ARWMC scores. HPτ-IR, Aβ-IR and WM ARWMC scores were all significantly higher in AD cases compared to controls, while SI values were similar between groups. ARWMC scores correlated with HPτ-IR, Aβ-IR and SI in various regions, however, linear regression revealed that only HPτ-IR was a significant independent predictor of ARWMC scores.

CONCLUSIONS

Here we have shown that increasing cortical HPτ burden independently predicted the severity of WMH indicating its potentially important role in the pathogenesis of WM damage. Moreover, our findings suggest that in AD patients the presence of WMH may indicate cortical AD-associated pathology rather than SVD. Further studies are warranted to elucidate the pathological processes that lead to WM damage and to clarify if WMH may serve as a general biomarker for cortical AD-associated pathology.

摘要

介绍

脑白质病变(WML),在 T2 加权 MRI 上表现为脑白质高信号(WMH),包含脑白质(WM)的结构损伤和完整性丧失,通常被认为与小血管疾病(SVD)有关。然而,有人认为 WM 损伤也可能是皮质阿尔茨海默病(AD)病理即过度磷酸化的 tau(HPτ)和淀粉样β(Aβ)继发的轴突退行性丢失的结果。在这里,我们研究了 HPτ、Aβ 和 SVD 对 WMH 严重程度的影响。

结果

36 个人死后右侧固定大脑半球(平均年龄 84.4±7.7 岁;男性 16 例,女性 20 例)包含不同数量的 AD 病理(AD:23 例,对照组:13 例)接受 T2 加权 MRI,根据年龄相关性白质改变量表(ARWMC)评估 WMH。在解剖后,使用来自右侧半球额、颞、顶和枕叶的组织样本,我们通过测量 AT8 免疫反应性(HPτ-IR)和 4G8 免疫反应性(Aβ-IR)的覆盖面积百分比来定量评估皮质 HPτ 和 Aβ 病理负担,并通过计算 WM 动脉/小动脉的硬化指数(SI)来评估 WM SVD 的严重程度。将 HPτ-IR、Aβ-IR 和 WM SVD 与 ARWMC 评分进行比较。与对照组相比,AD 病例的 HPτ-IR、Aβ-IR 和 WM ARWMC 评分均显著升高,而两组之间的 SI 值相似。ARWMC 评分与各区域的 HPτ-IR、Aβ-IR 和 SI 均相关,但线性回归显示仅 HPτ-IR 是 ARWMC 评分的显著独立预测因子。

结论

在这里,我们表明皮质 HPτ 负荷的增加独立预测了 WMH 的严重程度,表明其在 WM 损伤发病机制中具有潜在的重要作用。此外,我们的发现表明,在 AD 患者中,WMH 的存在可能表明与皮质 AD 相关的病理,而不是 SVD。需要进一步的研究来阐明导致 WM 损伤的病理过程,并阐明 WMH 是否可以作为皮质 AD 相关病理的一般生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4589169/dbd59960bea7/40478_2015_240_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4589169/ad7b4a6b4651/40478_2015_240_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4589169/b4141e7b3d87/40478_2015_240_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4589169/66da24930b14/40478_2015_240_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4589169/dbd59960bea7/40478_2015_240_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4589169/ad7b4a6b4651/40478_2015_240_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4589169/b4141e7b3d87/40478_2015_240_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4589169/66da24930b14/40478_2015_240_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ef/4589169/dbd59960bea7/40478_2015_240_Fig4_HTML.jpg

相似文献

1
Cortical tau load is associated with white matter hyperintensities.皮质 Tau 负荷与脑白质高信号相关。
Acta Neuropathol Commun. 2015 Sep 30;3:60. doi: 10.1186/s40478-015-0240-0.
2
Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.阿尔茨海默病和正常老年人大脑白质中的血管外纤维蛋白原:纤维蛋白原作为阿尔茨海默病生物标志物的意义。
Brain Pathol. 2019 May;29(3):414-424. doi: 10.1111/bpa.12685. Epub 2019 Jan 29.
3
Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology.阿尔茨海默病患者的额部白质病变与小血管疾病和 AD 相关的皮质病理学均有关。
Acta Neuropathol. 2021 Dec;142(6):937-950. doi: 10.1007/s00401-021-02376-2. Epub 2021 Oct 4.
4
Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.阿尔茨海默病中的顶叶白质病变与皮质神经退行性病变相关,但与小血管疾病无关。
Acta Neuropathol. 2017 Sep;134(3):459-473. doi: 10.1007/s00401-017-1738-2. Epub 2017 Jun 21.
5
Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease.皮质脑活检中的淀粉样蛋白和tau 蛋白与阿尔茨海默病。
Ann Neurol. 2010 Oct;68(4):446-53. doi: 10.1002/ana.22100.
6
Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.区域脑白质高信号与认知正常和轻度认知障碍老年人的阿尔茨海默病生物标志物。
J Alzheimers Dis. 2023;92(1):323-339. doi: 10.3233/JAD-220846.
7
Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.脑淀粉样蛋白沉积与脑白质高信号纵向变化的关系。
Alzheimers Res Ther. 2024 Mar 7;16(1):50. doi: 10.1186/s13195-024-01417-8.
8
Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.将脑白质高信号与阿尔茨海默病的区域性皮质变薄、淀粉样蛋白沉积和突触密度丧失联系起来。
Alzheimers Dement. 2024 Jun;20(6):3931-3942. doi: 10.1002/alz.13845. Epub 2024 Apr 22.
9
Alzheimer's disease-related plaques in nondemented subjects.非痴呆患者的阿尔茨海默病相关斑块。
Alzheimers Dement. 2014 Sep;10(5):522-9. doi: 10.1016/j.jalz.2012.12.009. Epub 2014 Apr 16.
10
Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions.脑白质完整性的丧失反映了阿尔茨海默病定义区域的 tau 积聚。
Neurology. 2018 Jul 24;91(4):e313-e318. doi: 10.1212/WNL.0000000000005864. Epub 2018 Jun 29.

引用本文的文献

1
White matter hyperintensities and their impact in brain structure and function in alzheimer's disease and behavioral variant frontotemporal dementia across Latin America and the United States: a cross-sectional study.白质高信号及其对拉丁美洲和美国阿尔茨海默病及行为变异型额颞叶痴呆脑结构和功能的影响:一项横断面研究。
Alzheimers Res Ther. 2025 Aug 12;17(1):188. doi: 10.1186/s13195-025-01832-5.
2
Characterizing spatiotemporal white matter hyperintensity pathophysiology in vivo to disentangle vascular and neurodegenerative contributions.在体内表征白质高信号的时空病理生理学,以厘清血管和神经退行性病变的影响。
medRxiv. 2025 Jun 11:2025.06.10.25329342. doi: 10.1101/2025.06.10.25329342.
3

本文引用的文献

1
The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment.白质高信号对轻度认知障碍中神经退行性变的影响。
Alzheimers Dement. 2015 Dec;11(12):1510-1519. doi: 10.1016/j.jalz.2015.05.014. Epub 2015 Jun 13.
2
Tract-based analysis of white matter degeneration in Alzheimer's disease.基于纤维束的阿尔茨海默病白质变性分析。
Neuroscience. 2015 Aug 20;301:79-89. doi: 10.1016/j.neuroscience.2015.05.049. Epub 2015 May 27.
3
White matter hyperintensities, cognitive impairment and dementia: an update.
Oligodendroglia in Ageing and Age-Dependent Neurodegenerative Diseases.
衰老及年龄相关性神经退行性疾病中的少突胶质细胞
Adv Neurobiol. 2025;43:363-405. doi: 10.1007/978-3-031-87919-7_13.
4
White matter fractional anisotropy decreases precede hyperintensities in Alzheimer's disease.在阿尔茨海默病中,白质分数各向异性降低先于高信号出现。
Cell Rep Med. 2025 Jun 17;6(6):102138. doi: 10.1016/j.xcrm.2025.102138. Epub 2025 May 20.
5
Trajectory of changes in myelin basic protein levels in cerebrospinal fluid during ageing and its association with biomarkers of Alzheimer's disease.衰老过程中脑脊液中髓鞘碱性蛋白水平的变化轨迹及其与阿尔茨海默病生物标志物的关联
Transl Psychiatry. 2025 Apr 16;15(1):149. doi: 10.1038/s41398-025-03369-5.
6
The Role of Glial Cell Senescence in Alzheimer's Disease.神经胶质细胞衰老在阿尔茨海默病中的作用
J Neurochem. 2025 Mar;169(3):e70051. doi: 10.1111/jnc.70051.
7
Perivascular space and white matter hyperintensities in Alzheimer's disease: associations with disease progression and cognitive function.阿尔茨海默病中的血管周围间隙与白质高信号:与疾病进展和认知功能的关联
Alzheimers Res Ther. 2025 Mar 18;17(1):62. doi: 10.1186/s13195-025-01707-9.
8
Neuronal and glial dysfunction, white matter hyperintensities and cognition in ageing and Alzheimer's disease.衰老和阿尔茨海默病中的神经元和神经胶质功能障碍、白质高信号与认知
Brain Commun. 2025 Feb 14;7(1):fcaf068. doi: 10.1093/braincomms/fcaf068. eCollection 2025.
9
Brain microstructure alterations in subjective cognitive decline: a multi-component T2 relaxometry study.主观认知衰退中的脑微结构改变:一项多成分T2弛豫测量研究
Brain Commun. 2025 Jan 16;7(1):fcaf017. doi: 10.1093/braincomms/fcaf017. eCollection 2025.
10
Neuropathological contributions to grey matter atrophy and white matter hyperintensities in amnestic dementia.遗忘型痴呆中灰质萎缩和白质高信号的神经病理学贡献。
Alzheimers Res Ther. 2025 Jan 9;17(1):16. doi: 10.1186/s13195-024-01633-2.
脑白质高信号、认知障碍与痴呆:最新进展。
Nat Rev Neurol. 2015 Mar;11(3):157-65. doi: 10.1038/nrneurol.2015.10. Epub 2015 Feb 17.
4
Quantitative neuropathological assessment to investigate cerebral multi-morbidity.定量神经病理学评估研究脑多系统疾病。
Alzheimers Res Ther. 2014 Nov 28;6(9):85. doi: 10.1186/s13195-014-0085-y. eCollection 2014.
5
Advances in MRI biomarkers for the diagnosis of Alzheimer's disease.用于阿尔茨海默病诊断的磁共振成像生物标志物研究进展。
Biomark Med. 2014;8(9):1151-69. doi: 10.2217/bmm.14.42.
6
White matter hyperintensities as early and independent predictors of Alzheimer's disease risk.脑白质高信号作为阿尔茨海默病风险的早期独立预测指标。
J Alzheimers Dis. 2014;42 Suppl 4:S393-400. doi: 10.3233/JAD-141473.
7
Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.脑小血管病与脑脊液生物标志物检测阿尔茨海默病病理的相关性。
JAMA Neurol. 2014 Jul 1;71(7):855-62. doi: 10.1001/jamaneurol.2014.754.
8
Association between neuropathology and brain volume in the Framingham Heart Study.弗雷明汉心脏研究中神经病理学与脑容量之间的关联。
Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):219-25. doi: 10.1097/WAD.0000000000000032.
9
Pathology of clinical and preclinical Alzheimer's disease.临床和临床前阿尔茨海默病的病理学。
Eur Arch Psychiatry Clin Neurosci. 2013 Nov;263 Suppl 2:S137-45. doi: 10.1007/s00406-013-0449-5.
10
Neuropathologic basis of white matter hyperintensity accumulation with advanced age.随着年龄的增长,脑白质高信号蓄积的神经病理学基础。
Neurology. 2013 Sep 10;81(11):977-83. doi: 10.1212/WNL.0b013e3182a43e45. Epub 2013 Aug 9.